Crowdonomics
All companies
NowRx logo

NowRx

Operating

NowRx, Inc.

Retail & Consumer · Founded 2015

Technology-driven, on-demand pharmacy providing free, same-day delivery

Post-money valuation ⓘ
$303.4M
As of May 2022 · from Reg A Offering (2021) · pre-money + amount raised, not a traded price
Total raised
$53,221,233
Crowd $48.8M · Private $4.4M · 10 rounds since 2015
Latest share price
$10.85
Reg A+ · Preferred Stock · Aug 2021 offering price

Financials

FY2015–FY2021 · from SEC filings · hover any figure for its source
$0
−$247K
2015
$669K
−$663K
2016
$2.5M
−$1.1M
2017
$4.7M
−$3.0M
2018
$7.1M
−$5.8M
2019
$13.4M
−$9.6M
2020
$21.8M
−$13.4M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed*
FY2016 audited
FY2017
FY2018 audited
FY2019 audited
FY2020 audited
FY2021
Income statement
Revenue
$0
$668,695
$2,497,667
$4,743,075
$7,074,886
$13,414,400
$21,758,004
Cost of goods sold
$0
$573,791
-$2,162,965
-$4,229,662
-$6,174,511
-$11,932,203
-$20,137,644
Gross margin
—
14%
13%
11%
13%
11%
7%
Net income
-$247,240
-$662,535
-$1,092,881
-$3,000,901
-$5,786,196
-$9,558,349
-$13,395,075
Taxes paid
$0
$0
$0
—
—
—
—
Balance sheet
Cash
$160,765
$175,519
$52,212
$4,253,065
$8,873,706
$8,873,706
$5,961,641
Accounts receivable
$12,826
$128,552
$269,788
$356,316
$1,156,705
$1,156,705
$1,461,156
Total assets
$308,161
$459,485
$752,343
$5,681,761
$13,554,205
$15,101,757
$17,180,257
Short-term debt
$109,551
$210,910
$307,102
—
—
—
—
Long-term debt
$445,000
$1,117,500
$2,374,463
$0
—
$1,939,638
—
Total liabilities
$554,551
$1,328,410
$2,681,565
$589,495
$4,507,303
$4,507,303
$8,591,590
Other
Headcount
—
12
16
23
—
82
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$6.0M
Valuation cap
$25.3M
pre-money
$17.0M
est. pre-money
$65.0M
pre-money
$275.0M
pre-money
Reg CF · Debt · Apr 2017
Reg CF · Preferred · Jan 2018
Reg A+ · Equity · Jan 2018
Reg A+ · Equity · Aug 2019
Reg A+ · Preferred · Aug 2021

Blue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher. Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth, so don't compare them with the other bars.

Share price over rounds

log scale
$10.85$0.0329$0.0001
Jun 2015Aug 2021
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Sep 27, 2021
Series B Preferred Stock · 27.1%Series A Preferred Stock · 37.0%Common Stock · 35.9%
ClassOutstandingVotes / shareShare of totalLiquidationLast price
Series B Preferred Stockpreferred6,497,179127.1%paid 1st—
Series A Preferred Stockpreferred8,853,173—37.0%2×—
Common Stock8,580,000135.9%—$10.85Aug 2021
Total23,930,352100%

Shares outstanding over timein today's share terms

15M7.7M0
Dec 2015Aug 2021
Common StockSeries A Preferred StockSeries B Preferred StockRound opened

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, May 2, 2022

  • New Direction IRA, Inc.6,062,029 Series B Preferred Stock93.3%of Series B Preferred
  • New Direction IRA, Inc.880,558 Series C Preferred Stock66.4%of Series C Preferred
  • Cary Breese3,617,600 Common Stock42.4%of
  • Sumeet Sheokand3,182,400 Common Stock37.3%of
  • New Direction IRA, Inc.3,124,028 Series A Preferred Stock35.3%of Series A Preferred
  • Barry Karlin1,700,000 Common Stock19.9%of
  • RMV Group, LLC185,106 Series C Preferred Stock13.9%of Series C Preferred

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $28.4M / $75MPost-money $303.4M
Reg A+ · Equity · Aug 2019Closedvia SeedInvest
Raised $20M / $20MInvestors 8,918Post-money $85M
Reg A+ · Equity · Jan 2018Closedvia SI Securities, LLC
Raised $0 / $7MEst. pre-money $17M
Raised $3.4MInvestors 54
Raised $209.2KPost-money $25.5M
Raised $595K
Reg CF · Debt · Apr 2017Closedvia SeedInvest
Raised $200K / $1MValuation cap $6M
Raised $50K

Team

4 people
Cary Breese
CEO
Sumeet Sheokand
Chief Technology Officer
Melissa Bostock
Pharmacist-in-Charge
Barry Karlin
Director

Names and titles as disclosed on SEC Form 1-A, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 9 annual reports (FY2017–FY2025)

8,918 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form 1-ZNov 14, 20220001104659-22-117331
    EDGAR
  • Form 1-SASep 28, 20220001104659-22-103473
    EDGAR
  • Form 1-KMay 2, 20220001104659-22-054011
    EDGAR
  • Form 253G2Apr 14, 20220001104659-22-046089
    EDGAR
  • Form 253G2Jan 21, 20220001104659-22-006426
    EDGAR
  • Form 1-UOct 12, 20210001104659-21-124903
    EDGAR
  • Form 253G2Sep 30, 20210001104659-21-120970
    EDGAR
  • Form QUALIFSep 29, 20219999999994-21-000323
    EDGAR
Source: ManualCIK 0001702206Share price $10.85

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.